Sunways Rohto Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 1986.
1986 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Sunways Rohto Pharmaceutical Private Limited

Sunways Rohto Pharmaceutical Private Limited, a active private limited company, was established on 22 May 1986 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1986PTC008689. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹3.25 M.

Formerly known as Deep Care Health Private Limited. It upholds a compliant status. Employing 87 professional, Its leadership includes Sumit Gupta (Additional Director), Anil Kumar Jagirdar (Nominee Director), Daiki Kato (Additional Director). Past directors included Sumit Gupta, Aatish Anupam Shroff, Lekh Raj Juneja. It holds ₹40.52 Cr open charges and ₹4.28 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 804, Gidc Dholka,, Ahmedabad, Gujarat, 387810.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ1986PTC008689

  • Registration Number

    008689

  • Incorporation Date

    22 May 1986

  • Authorized Capital

    ₹6.00 M

  • Paid-Up Capital

    ₹3.25 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 M
  • Paid Up Capital ₹ 3.25 M
  • Company Age 39 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 40.52 Cr
  • Satisfied Charges ₹ 4.28 Cr
  • Revenue Growth **** -7.18%
  • Profit Growth **** 41.94%
  • Ebitda **** 100.79%
  • Net Worth 3.50%
  • Total Assets **** 4.55%
Company report

Sunways Rohto Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sunways Rohto Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sunways Rohto Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Sumit Gupta Additional Director 16 Mar 2023 Current
Anil Kumar Jagirdar Nominee Director 30 Sep 2024 Current
Daiki Kato Additional Director 15 Jul 2020 Current
Anupam Kantilal Shroff Director 16 Oct 2017 Current
Bhadresh Kantilal Shroff Managing Director 20 Mar 1992 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 04 Sep 2024 Past
Pramod Abcsdd Director 16 Mar 2023 Past
Pramod Abcsdd Director 24 Jun 2020 Past
Pramod Abcsdd Director 29 Oct 2013 Past
Pramod Abcsdd Director 29 Oct 2013 Past
Pramod Abcsdd Director 31 Mar 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sunways Rohto Pharmaceutical.

Sunways Rohto Pharmaceutical Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.18% decrease. The company also saw a substantial improvement in profitability, with a 41.94% increase in profit. The company's net worth moved up by a moderate rise of 3.5%.

Sunways Rohto Pharmaceutical revenue growth over time
Sunways Rohto Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -7.18%
*******
*******
*******
*******
Revenue from Operations
*******
 -9.52%
*******
*******
*******
*******
Total Assets
*******
 4.55%
*******
*******
*******
*******
Profit or Loss
*******
 41.94%
*******
*******
*******
*******
Net Worth
*******
 3.50%
*******
*******
*******
*******
EBITDA
*******
 100.79%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sunways Rohto Pharmaceutical?

In 2023, Sunways Rohto Pharmaceutical had a public holding of 24.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹405,200,000.00

Satisfied Charges

₹42,836,524.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 40.50 Cr
  • Bank Of India : 0.02 Cr
Latest Charge Details
Date Lender Amount Status
30 May 2023 Hdfc Bank Limited ₹40.50 Cr Open
26 Apr 1988 Bank Of India ₹0.20 M Open
15 Mar 2022 Others ₹1.00 Cr Satisfied
04 Mar 2022 Others ₹3.00 Cr Satisfied
16 May 1989 Peoples Co- Op. Bank Ltd. ₹0.09 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sunways Rohto Pharmaceutical?

Sunways Rohto Pharmaceutical has a workforce of 87 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sunways Rohto Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunways Rohto Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sunways Rohto Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sunways Rohto Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Director Appointment

    The activity Anil Kumar Jagirdar was appointed as a Nominee Director was appointed as a Nominee Director on 30 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.

  • Balance Sheet

    The activity Sunways Rohto Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.

  • Charges

    A charge registered on 04 Mar 2022 via Charge ID 100574660 with Others was fully satisfied on 22 Sep 2023. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 405.00 M registered on 30 May 2023 with Charge ID 100734411 was modified on 02 Aug 2023. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 405.00 M with Charge ID 100734411 was registered on 30 May 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sunways Rohto Pharmaceutical Private Limited?

The CIN of Sunways Rohto Pharmaceutical Private Limited is U24231GJ1986PTC008689.

Where is Sunways Rohto Pharmaceutical Private Limited headquartered?

Sunways Rohto Pharmaceutical Private Limited is headquartered at 804, Gidc Dholka,, Ahmedabad, Gujarat, 387810.

When was Sunways Rohto Pharmaceutical Private Limited incorporated?

Sunways Rohto Pharmaceutical Private Limited was incorporated on 22 May 1986.

Who are the current directors of Sunways Rohto Pharmaceutical Private Limited?

The current directors of Sunways Rohto Pharmaceutical Private Limited are

What is the primary industry of Sunways Rohto Pharmaceutical Private Limited?

The primary industry of Sunways Rohto Pharmaceutical Private Limited is Manufacturing.

Is Sunways Rohto Pharmaceutical Private Limited a listed company?

Sunways Rohto Pharmaceutical Private Limited is unlisted.

What is the capital structure of Sunways Rohto Pharmaceutical Private Limited?

The authorized capital of Sunways Rohto Pharmaceutical Private Limited is ₹6.00 M, and the paid-up capital is ₹3.25 M.

What is the compliance status of Sunways Rohto Pharmaceutical Private Limited?

The compliance status of Sunways Rohto Pharmaceutical Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available